News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,359 Results
Type
Article (41766)
Company Profile (267)
Press Release (693309)
Multimedia
Podcasts (93)
Webinars (20)
Section
Business (205737)
Career Advice (2042)
Deals (35705)
Drug Delivery (133)
Drug Development (81872)
Employer Resources (175)
FDA (16610)
Job Trends (15056)
News (348445)
Policy (32951)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2613)
Accelerated approval (48)
Adcomms (26)
Allergies (174)
Alliances (49903)
ALS (211)
Alzheimer's disease (1808)
Antibody-drug conjugate (ADC) (450)
Approvals (17002)
Artificial intelligence (672)
Autoimmune disease (294)
Automation (56)
Bankruptcy (362)
Best Places to Work (11697)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (173)
Bladder cancer (196)
Brain cancer (72)
Breast cancer (755)
Cancer (5849)
Cardiovascular disease (473)
Career advice (1733)
Career pathing (42)
CAR-T (333)
CDC (56)
Celiac Disease (3)
Cell therapy (903)
Cervical cancer (47)
Clinical research (71139)
Collaboration (2076)
Company closure (5)
Compensation (1404)
Complete response letters (80)
COVID-19 (2750)
CRISPR (108)
C-suite (1136)
Cystic fibrosis (153)
Data (7961)
Decentralized trials (3)
Denatured (27)
Depression (162)
Dermatology (87)
Diabetes (590)
Diagnostics (6989)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (324)
Drug pricing (206)
Drug shortages (31)
Duchenne muscular dystrophy (285)
Earnings (92286)
Editorial (66)
Employer branding (21)
Employer resources (154)
Events (120346)
Executive appointments (1085)
FDA (20362)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1740)
Gene editing (234)
Generative AI (56)
Gene therapy (728)
GLP-1 (1063)
Government (4760)
Grass and pollen (6)
Guidances (408)
Healthcare (19124)
HIV (79)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (289)
Immuno-oncology (94)
Indications (195)
Infectious disease (3091)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (292)
Interviews (320)
IPO (16720)
IRA (50)
Job creations (3658)
Job search strategy (1438)
JPM (58)
Kidney cancer (19)
Labor market (101)
Layoffs (563)
Leadership (39)
Legal (7991)
Liver cancer (100)
Longevity (32)
Lung cancer (767)
Lymphoma (429)
Machine learning (61)
Management (59)
Manufacturing (1055)
MASH (190)
Medical device (14073)
Medtech (14198)
Mergers & acquisitions (20242)
Metabolic disorders (1513)
mRNA (206)
Multiple sclerosis (189)
NASH (17)
Neurodegenerative disease (419)
Neuropsychiatric disorders (105)
Neuroscience (3324)
Neurotech (1)
NextGen: Class of 2026 (6558)
Non-profit (4549)
Now hiring (78)
Obesity (711)
Opinion (288)
Ovarian cancer (222)
Pain (258)
Pancreatic cancer (309)
Parkinson's disease (363)
Partnered (33)
Patents (599)
Patient recruitment (673)
Peanut (64)
People (59935)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22181)
Phase 2 (31346)
Phase 3 (23294)
Pipeline (8843)
Policy (321)
Postmarket research (2579)
Preclinical (9479)
Press Release (66)
Prostate cancer (304)
Psychedelics (54)
Radiopharmaceuticals (325)
Rare diseases (1081)
Real estate (6010)
Recruiting (71)
Regulatory (25568)
Reports (57)
Research institute (2429)
Resumes & cover letters (354)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (176)
Series A (289)
Series B (215)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3653)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (87)
The Weekly (64)
Vaccines (1096)
Venture capital (108)
Weight loss (456)
Women's health (128)
Worklife (20)
Date
Today (134)
Last 7 days (774)
Last 30 days (3567)
Last 365 days (30252)
2026 (12879)
2025 (30249)
2024 (35323)
2023 (40188)
2022 (51333)
2021 (55886)
2020 (54324)
2019 (46889)
2018 (35286)
2017 (32372)
2016 (31740)
2015 (37805)
2014 (31541)
2013 (26609)
2012 (28789)
2011 (29491)
2010 (27515)
Location
Africa (754)
Alabama (93)
Alaska (7)
Arizona (349)
Arkansas (14)
Asia (40077)
Australia (6680)
California (13344)
Canada (3785)
China (1348)
Colorado (568)
Connecticut (580)
Delaware (411)
Europe (87641)
Florida (2002)
Georgia (436)
Hawaii (3)
Idaho (63)
Illinois (1056)
India (91)
Indiana (601)
Iowa (23)
Japan (541)
Kansas (133)
Kentucky (50)
Louisiana (41)
Maine (76)
Maryland (1601)
Massachusetts (9516)
Michigan (367)
Minnesota (726)
Mississippi (6)
Missouri (144)
Montana (34)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3510)
New Mexico (31)
New York (3491)
North Carolina (1696)
North Dakota (9)
Northern California (6692)
Ohio (400)
Oklahoma (23)
Oregon (41)
Pennsylvania (2686)
Puerto Rico (29)
Rhode Island (50)
South America (1115)
South Carolina (86)
South Dakota (2)
Southern California (5270)
Tennessee (215)
Texas (2130)
United States (47100)
Utah (398)
Vermont (1)
Virginia (324)
Washington D.C. (80)
Washington State (1063)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
735,359 Results for "octapharma usa inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Abram Scientific Secures $11.75M Series A Funding Led by Octapharma AG
February 25, 2026
·
6 min read
Press Releases
Takara Bio USA, Inc. Validates New Class of Spatial Technology with Benchmark Study for Cancer Research
April 20, 2026
·
3 min read
Press Releases
Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies
April 17, 2026
·
5 min read
Press Releases
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones
April 30, 2026
·
21 min read
Business
Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development
Octapharma USA, Inc. has appointed pharmaceutical industry veteran Kelly Hearn as Vice President of Commercial Development & Marketing, assuming immediate leadership of the product marketing team as the company continues to grow its presence in the U.S. market.
May 20, 2024
·
2 min read
Press Releases
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026
February 26, 2026
·
3 min read
Press Releases
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
May 20, 2026
·
3 min read
Press Releases
ASAHI INTECC USA ANNOUNCES DISTRIBUTION OF QXMEDICAL BOOSTING CATHETER
May 4, 2026
·
3 min read
Press Releases
Codexis to share RNA manufacturing advances at TIDES USA
April 29, 2026
·
2 min read
FDA
Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®, the First VWF Concentrate for Prophylaxis in All Types of VWD
Octapharma USA , Inc. announced the U.S. Food and Drug Administration (FDA) has granted orphan drug exclusivity for wilate®, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection, for routine prophylaxis to reduce the frequency of bleeding episodes in adults and children 6 years of age and older with von Willebrand disease (VWD).
April 29, 2024
·
4 min read
1 of 73,536
Next
